Inipharm

Developer of therapeutic solutions for treating severe liver diseases

placeSeattle, Washington, United States calendar_todayFounded 2018 language inipharm.com

Innovation

16 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 332 times.

YearFilings
20213
20229
202310
20247
20257
20261

Investor mix

4 investors on record; lead investors include 5AM Ventures, Wu Capital.

Investor typeCountShare
Venture capital250%
Private equity125%
Other / undisclosed125%
Coming soon